Correlation Between Forte Biosciences and Transcode Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Forte Biosciences and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Forte Biosciences and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Forte Biosciences and Transcode Therapeutics, you can compare the effects of market volatilities on Forte Biosciences and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Forte Biosciences with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Forte Biosciences and Transcode Therapeutics.

Diversification Opportunities for Forte Biosciences and Transcode Therapeutics

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Forte and Transcode is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Forte Biosciences and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Forte Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Forte Biosciences are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Forte Biosciences i.e., Forte Biosciences and Transcode Therapeutics go up and down completely randomly.

Pair Corralation between Forte Biosciences and Transcode Therapeutics

Given the investment horizon of 90 days Forte Biosciences is expected to generate 1.31 times more return on investment than Transcode Therapeutics. However, Forte Biosciences is 1.31 times more volatile than Transcode Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about 0.13 per unit of risk. If you would invest  783.00  in Forte Biosciences on May 15, 2025 and sell it today you would earn a total of  293.00  from holding Forte Biosciences or generate 37.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Forte Biosciences  vs.  Transcode Therapeutics

 Performance 
       Timeline  
Forte Biosciences 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Forte Biosciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Forte Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
Transcode Therapeutics 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Transcode Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Transcode Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Forte Biosciences and Transcode Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Forte Biosciences and Transcode Therapeutics

The main advantage of trading using opposite Forte Biosciences and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Forte Biosciences position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.
The idea behind Forte Biosciences and Transcode Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital